JOGC

Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women

        Menopause is an important milestone and may be one of the first times a woman seeks medical advice around issues of long-term health promotion and disease prevention. Women typically begin to experience menopausal symptoms between 40 and 58 years of age, spending at least one third of their lives after menopause.
        • National Institutes of Health
        National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms.
        The 3 main causes of illness and disability in developed countries for postmenopausal women are CVD, cancer, and osteoporosis-associated fractures.
        As outlined in the following chapters of this update to the Canadian Consensus Conference on Menopause
        • Bélisle S.
        • Blake J.
        SOGC Menopause Guidelines Committee. Canadian Consensus Conference on Menopause, 2006 update. SOGC Clinical Practice Guidelines, No. 171, February 2006.
        and the Canadian Consensus Conference on Osteoporosis,
        • Brown J.P.
        • Fortier M.
        SOGC Osteoporosis Guidelines Committee. Canadian Consensus Conference on Osteoporosis, 2006 update. SOGC Clinical Practice Guidelines, No. 172, February 2006.
        many of the risk factors for the conditions prevalent among older women are modifiable through changes in lifestyle.
        To read this article in full you will need to make a payment

        REFERENCES

          • National Institutes of Health
          National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms.
          Ann Intern Med. 2005; 142: 1003-1013
        1. Women’s Health Initiative [website]. Women’s Health Initiative, Bethesda, Maryland2010 (Available at:) (Accessed 2014 July 8)
          • Bélisle S.
          • Blake J.
          SOGC Menopause Guidelines Committee. Canadian Consensus Conference on Menopause, 2006 update. SOGC Clinical Practice Guidelines, No. 171, February 2006.
          J Obstet Gynaecol Can. 2006; 28: S1-94
          • Brown J.P.
          • Fortier M.
          SOGC Osteoporosis Guidelines Committee. Canadian Consensus Conference on Osteoporosis, 2006 update. SOGC Clinical Practice Guidelines, No. 172, February 2006.
          J Obstet Gynaecol Can. 2006; 28: S95-112
          • Health Canada
          Eating well with Canada’s food guide.
          Ottawa, Health Canada2011 (Available at:) (Accessed 2014 Mar 11)
          • Kannel W.B.
          Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.
          Am Heart J. 1987; 114: 413-419
          • Hu F.B.
          • Manson J.E.
          • Willett W.C.
          Types of dietary fat and risk of coronary heart disease: a critical review.
          J Am Coll Nutr. 2001; 20: 5-19
          • Genest J.
          • McPherson R.
          • Frohlich J.
          • Anderson T.
          • Campbell N.
          • Carpentier A.
          • et al.
          2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult — 2009 recommendations.
          Can J Cardiol. 2009; 25: 567-579
          • Prior J.C.
          • Nielsen J.D.
          • Hitchcock C.L.
          • Williams L.A.
          • Vigna Y.M.
          • Dean C.B.
          Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy.
          Clin Sci (Lond). 2007; 112: 517-525
          • Canada Health
          Sodium in Canada [website]. Ottawa, Health Canada2012 (Available at:) (Accessed 2014 March 11)
          • Sacks F.M.
          • Bray G.A.
          • Carey V.J.
          • Smith S.R.
          • Ryan D.H.
          • Anton S.D.
          • et al.
          Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.
          N Engl J Med. 2009; 360: 859-873
          • Knekt P.
          • Jarvinen R.
          • Reunanen A.
          • Maatela J.
          Flavonoid intake and coronary mortality in Finland: a cohort study.
          BMJ. 1996; 312: 478-481
          • Geleijnse J.M.
          • Launer L.J.
          • Hofman A.
          • Pols H.A.
          • Witteman J.C.
          Tea flavonoids may protect against atherosclerosis: the Rotterdam Study.
          Arch Intern Med. 1999; 159: 2170-2174
          • Rimm E.B.
          • Willett W.C.
          • Hu F.B.
          • Sampson L.
          • Colditz G.A.
          • Manson J.E.
          • et al.
          Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.
          JAMA. 1998; 279: 359-364
          • Jenkins D.J.
          • Kendall C.W.
          • Jackson C.J.
          • Connelly P.W.
          • Parker T.
          • Faulkner D.
          • et al.
          Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.
          Am J Clin Nutr. 2002; 76: 365-372
          • Bolland M.J.
          • Grey A.
          • Avenell A.
          • Gamble G.D.
          • Reid I.R.
          Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis.
          BMJ. 2011; 342: d2040
          • Shufelt C.L.
          • Merz C.N.
          • Prentice R.L.
          • Pettinger M.B.
          • Rossouw J.E.
          • Aroda V.R.
          • et al.
          Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study.
          Menopause. 2013; 21: 260-266
          • Hanley D.A.
          • Cranney A.
          • Jones G.
          • Whiting S.
          • Leslie W.D.
          • Cole D.
          • et al.
          Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.
          CMAJ. 2010; 182 (Epub 2010 Jul 12): E610-8
          • Holick M.F.
          Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease.
          Am J Clin Nutr. 2004; 80: 1678S-1688S
          • Storm D.
          • Eslin R.
          • Porter E.S.
          • Musgrave K.
          • Vereault D.
          • Patton C.
          • et al.
          Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.
          J Clin Endocrinol Metab. 1998; 83: 3817-3825
          • Dawson-Hughes B.
          • Harris S.S.
          • Krall E.A.
          • Dallal G.E.
          Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
          N Engl J Med. 1997; 337: 670-676
          • Canada Osteoporosis
          Calcium: an important nutrient that builds stronger bones [website]. Osteoporasis Canada, Toronto2014 (Available at:) (Accessed 2014 Mar 11)
          • World Cancer Research Fund/American Institute for Cancer Research
          Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. American Institute for Cancer Research, Washington, DC2007: 31-40
          • Sprague B.L.
          • Trentham-Dietz A.
          • Egan K.M.
          • Titus-Ernstoff L.
          • Hampton J.M.
          • Newcomb P.A.
          Proportion of invasive breast cancer attributable to risk factors modifiable after menopause.
          Am J Epidemiol. 2008; 168 (Epub 2008 Jun 13): 404-411
          • Canadian Cancer Society
          Nutrition and fitness [website]. Canadian Cancer Society, Toronto2014 (Available at) (Accessed 2014 Mar 11)
          • Canadian Society for Exercise Physiology
          Canadian physical activity guidelines and Canadian sedentary behaviour guidelines [website]. Canadian Society for Exercise Physiology, Ottawa2014 (Available at:) (Accessed 2014 Mar 11)
          • Osteoporosis Canada
          Exercise for healthy bones [website]. Osteoporasis Canada, Toronto2014 (Available at:) (Accessed 2014 Mar 11)
          • Yusuf S.
          • Hawken S.
          • Ounpuu S.
          • Dans T.
          • Avezum A.
          • Lanas F.
          • INTERHEART Study Investigators
          • et al.
          Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study.
          Lancet. 2004; 364: 937-952
          • Smith G.N.
          • Pudwell J.
          • Roddy M.
          The Maternal Health Clinic: a new window of opportunity for early heart disease risk screening and intervention for women with pregnancy complications.
          J Obsetet Gynaecol Can. 2013; 35: 831-839
          • Mosca L.
          • Benjamin E.J.
          • Berra K.
          • Bezanson J.L.
          • Dolor R.J.
          • Lloyd-Jones D.
          • et al.
          Effectiveness-based guidelines for the prevention of cardiovascular disease in women — 2011 update.
          J Am Coll Cardiol. 2011; 57: 1404-1423
          • Pruthi S.
          Mayo Clinic. Is there a connection between menopause and high blood pressure? [website]. Scottsdale, Arizona, Mayo Clinic2013 (Available at:) (Accessed 2014 Mar 11)
          • Canada Hypertension
          Canadian Hypertension Education Program [website]. Markham, Ontario, Hypertension Canada2014 (Available at:) (Accessed 2014 Mar 11)
          • Anderson T.J.
          • Grégoire J.
          • Hegele R.A.
          • Couture P.
          • Mancini G.B.
          • McPherson R.
          • et al.
          2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.
          Can J Cardiol. 2013; 29: 151-167
          • Carmina E.
          • Lobo R.A.
          Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.
          J Clin Endocrinol Metab. 1999; 84: 1897-1899
          • Canada Health
          Canadian Guidelines for Body Weight Classification in Adults [website]. Health Canada, Ottawa2014 (Available at:) (Accessed 2014 Mar 11)
          • NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US)
          Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. National Heart, Lung, and Blood Institute, Bethesda1998 (Available at) (Accessed 2014 Mar 11)
          • Canadian Centre on Substance Abuse
          Canada’s Low-Risk Alcohol Drinking Guidelines. CCSA, Ottawa2013 (Available at) (Accessed 2014 Mar 11)
          • Canadian Action Network for the Advancement
          Dissemination and Adoption of Practice-Informed Tobacco Treatment. Smoking Cessation Knowledge Exchange Network & Clinical Practice Guideline [website]. Centre for Addiction and Mental Health, Toronto2012 (Available at) (Accessed 2014 Mar 12)
          • Witte A.V.
          • Fobker M.
          • Gellner R.
          • Knecht S.
          • Flöela A.
          Caloric restriction improves memory in elderly humans.
          Proc Natl Acad Sci U S A. 2009; 106: 1255-1260
          • Pines A.
          • Berry E.M.
          Exercise in the menopause — an update.
          Climacteric. 2007; 10: 42-46
          • FRAX
          WHO fracture assessment tool [website]. Sheffield, England, World Health Organization Collaborating Centre for Metabolic Bone Diseases2012 (Available at:) (Accessed 2014 Mar 12)
          • Subak L.L.
          • Johnson C.
          • Whitcomb E.
          • Boban D.
          • Saxton J.
          • Brown J.S.
          Does weight loss improve incontinence in moderately obese women?.
          Int Urogynecol J Pelvic Floor Dysfunct. 2002; 13: 40-43
          • Townsend M.K.
          • Danforth K.N.
          • Rosner B.
          • Curhan G.C.
          • Resnick N.M.
          • Grodstein F.
          Body mass index, weight gain, and incident urinary incontinence in middle-aged women.
          Obstet Gynecol. 2007; 110: 346-353
          • Danforth K.N.
          • Shah A.D.
          • Townsend M.K.
          • Lifford K.L.
          • Curhan G.C.
          • Resnick N.M.
          • et al.
          Physical activity and urinary incontinence among healthy, older women.
          Obstet Gynecol. 2007; 109: 721-727
          • Olié V.
          • Canonico M.
          • Scarabin P.Y.
          Postmenopausal hormone therapy and venous thromboembolism.
          Thromb Res. 2011; 127: S26-9
          • Olié V.
          • Plu-Bureau G.
          • Conard J.
          • Horellou M.H.
          • Canonico M.
          • Scarabin P.Y.
          Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
          Menopause. 2011; 18: 488-493
          • Laliberté F.
          • Dea K.
          • Duh M.S.
          • Kahler K.H.
          • Rolli M.
          • Lefebvre P.
          Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
          Menopause. 2011; 18: 1052-1059